News Sentiment

VACH sentiment intelligence

Voyager Acquisition Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 40 relevant articles
Exchange NASDAQ United States
Sector Financial Services Market context
Industry Shell Companies Read-through group
Latest close 17.11 Week of 12 Jun 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Deals and strategy

92/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+61.5% over one week, +65.2% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Voyager Acquisition Corp (VACH) Technical Analysis: Support, Resistance, Indicators & Moving Averages

Market Reaction

Price moving ahead of tone

65/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Deals and strategy 92/100 classification
One-week reaction 61.5% Price confirming higher
Trend fit Trend active 65.2% over four weeks
Fair value 61.7% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 22
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 16
TradingKey 9
marketscreener.com 2
AD HOC NEWS 2
Mondaq 1
FinancialContent 1
Minichart 1
MarketBeat 1

Event Lens

What the news is about

Classified themes
Deals and strategy 37
Market update 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 40
Mondaq Direct company coverage

Appleby Advises Voyager Acquisition Corp. In Its Business Combination With Veraxa Biotech AG

Appleby served as Cayman Islands legal counsel to Voyager Acquisition Corp. in its business combination with VERAXA Biotech AG, an innovative biopharmaceutical company focused on cancer therapies. The business combination was approved by shareholders in February and March 2026, a

Tone
Neutral 50/100
Event
Deals and strategy
Published
19 Jun 2026 14:39
Source
Mondaq
FinancialContent Direct company coverage

Voyager Acquisition Corp - Class A Ordinary Shares (Nasdaq:VACH) Stock Quote

This article provides a stock quote for Voyager Acquisition Corp - Class A Ordinary Shares (VACH) on Nasdaq, showing its current price of 17.11 as of June 10, 2026. It also includes performance metrics, recent news on its business combination with VERAXA Biotech AG, and frequentl

Tone
Neutral 50/100
Event
Deals and strategy
Published
10 Jun 2026 23:08
Source
FinancialContent
Stock Titan Direct company coverage

[25-NSE] Voyager Acquisition Corp./Cayman Islands SEC Filing

Voyager Acquisition Corp. (VACH) has delisted its Class A shares, warrants, and units from the Nasdaq Stock Market, as announced in an SEC Form 25-NSE filing. This action signifies a voluntary withdrawal following proper procedures by both VACH and Nasdaq, certifying compliance w

Tone
Negative 29/100
Event
Deals and strategy
Published
10 Jun 2026 23:08
Source
Stock Titan
Stock Titan Direct company coverage

Voyager Acquisition (NASDAQ: VACH) inks $27.5M note and $50M Veraxa share deal

Voyager Acquisition Corp. (NASDAQ: VACH) and Veraxa Biotech AG have secured a financing package through a $27.5 million senior secured note offering and a $50 million share purchase agreement with Lincoln Park Capital. This financing aims to support their planned business combina

Tone
Positive 67/100
Event
Deals and strategy
Published
29 May 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Magnetar Group Holds 0 Shares in Voyager Acquisition (VACH)

Magnetar Group filed a Schedule 13G/A amendment for Voyager Acquisition Corp. (VACH) reporting that its reporting group, including Magnetar Financial LLC and related entities, beneficially owns 0 shares or approximately 0% of VACH's Class A ordinary shares as of March 31, 2026. T

Tone
Neutral 50/100
Event
Deals and strategy
Published
18 May 2026 20:38
Source
Stock Titan
AD HOC NEWS Direct company coverage

Voyager Acquisition’s Redemption Wave Leaves SPAC in Precarious State Ahead of Merger

Voyager Acquisition experienced a massive redemption wave, with 99.67% of shareholders cashing out ahead of its merger with Veraxa Biotech, leaving just 82,685 public shares and shrinking its trust account to $885,000. This exodus has left the SPAC in a precarious financial state

Tone
Negative 9/100
Event
Deals and strategy
Published
17 May 2026 17:37
Source
AD HOC NEWS
Stock Titan Direct company coverage

99.67% redemptions: Voyager Acquisition (VACH) delays Q1 2026 10-Q

Voyager Acquisition Corp. (VACH) has filed a Form 12b-25 indicating a delay in filing its Q1 2026 10-Q report, primarily due to needing more time to finalize financial statements related to its pending business combination with Veraxa Biotech AG and complete the independent accou

Tone
Negative 12/100
Event
Deals and strategy
Published
15 May 2026 18:14
Source
Stock Titan
Stock Titan Direct company coverage

Goldman Sachs (VACH) joint Schedule 13G/A shows 683,732 shares (2.7%)

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC filed an amended Schedule 13G/A, disclosing a 2.7% stake in Voyager Acquisition Corp. (VACH) through 683,732 shared voting and dispositive Class A ordinary shares. This filing is a passive investment disclosure, indicating

Tone
Neutral 50/100
Event
Deals and strategy
Published
11 May 2026 19:38
Source
Stock Titan
Stock Titan Direct company coverage

Wolverine Asset Management (VACH) files 13G/A — reports 0 shares held

Wolverine Asset Management (VACH) and associated entities have filed an amended Schedule 13G/A, reporting that they hold 0 Class A Ordinary Shares in Voyager Acquisition Corp., translating to 0% beneficial ownership. This filing is an administrative disclosure indicating that the

Tone
Neutral 50/100
Event
Deals and strategy
Published
15 Apr 2026 23:40
Source
Stock Titan
AD HOC NEWS Direct company coverage

Voyager Acquisition Clears Key Hurdle for Nasdaq Relaunch

Voyager Acquisition has filed a mandatory executive clawback policy with the SEC, a critical step towards its Nasdaq listing as Veraxa Biotech AG. This regulatory compliance, which led to a 6% rise in Voyager's shares, addresses a major requirement for the new entity (VRXA) to be

Tone
Positive 70/100
Event
Deals and strategy
Published
05 Apr 2026 04:40
Source
AD HOC NEWS
Minichart Direct company coverage

Voyager Acquisition Corp. 2025 Amended Annual Report (Form 10-K/A) Filing, Compliance, and Certifications

Voyager Acquisition Corp. (Nasdaq: VACHU) has filed Amendment No. 1 to its 2025 Annual Report on Form 10-K/A, primarily to include its Policy on Recoupment of Incentive Compensation, as required by SEC Rule 10D-1. This amendment clarifies corporate governance around executive acc

Tone
Neutral 50/100
Event
Deals and strategy
Published
04 Apr 2026 15:10
Source
Minichart
Stock Titan Direct company coverage

Clawback policy added to Voyager Acquisition (NASDAQ: VACH) 10-K

Voyager Acquisition Corp. (NASDAQ: VACH) filed an amendment to its 2025 annual report (10-K/A) to include its Policy on Recoupment of Incentive Compensation, which was adopted on March 10, 2025, but inadvertently omitted from the original filing. The company clarified that this w

Tone
Neutral 50/100
Event
Deals and strategy
Published
02 Apr 2026 20:10
Source
Stock Titan
Stock Titan Direct company coverage

VACH SEC Filings - Voyager Acquisition Corp 10-K, 10-Q, 8-K Forms

This page provides a comprehensive resource for Voyager Acquisition Corp. (VACH) SEC filings, including 10-K, 10-Q, 8-K, and insider trading forms. It features AI-generated summaries, sentiment analysis by Rhea-AI, and market reaction data for each filing. Recent filings include

Tone
Positive 66/100
Event
Deals and strategy
Published
31 Mar 2026 16:10
Source
Stock Titan
MarketBeat Direct company coverage

Voyager Acquisition (NASDAQ:VACH) Trading Down 5% - What's Next?

Voyager Acquisition (NASDAQ:VACH) experienced a 5% drop in share price during mid-day trading, reaching as low as $10.78, with significantly reduced trading volume. Despite institutional investors increasing their positions, analyst sentiment remains negative, with Weiss Ratings

Tone
Negative 15/100
Event
Deals and strategy
Published
31 Mar 2026 06:09
Source
MarketBeat
The Manila Times Direct company coverage

Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG

Voyager Acquisition Corporation announced that holders of approximately 99.67% of its Class A ordinary shares elected to redeem their shares in connection with its business combination with VERAXA Biotech AG. As a result, approximately $885,556 will remain in Voyager's trust acco

Tone
Negative 34/100
Event
Deals and strategy
Published
27 Mar 2026 15:39
Source
The Manila Times
Stock Titan Direct company coverage

Voyager Acquisition Corp. (NASDAQ: VACH) shareholders approve merger; heavy redemptions reported

Voyager Acquisition Corp. (VACH) shareholders have approved a multi-step merger with Veraxa Biotech AG, along with related corporate actions and governance provisions. Despite the approval, a significant number of Class A Ordinary Shares were redeemed, resulting in only approxima

Tone
Negative 38/100
Event
Deals and strategy
Published
18 Mar 2026 19:39
Source
Stock Titan
Stock Titan Direct company coverage

Voyager (NASDAQ: VACH) clears VERAXA merger as 99.67% of Class A shares redeem

Voyager Acquisition Corp. (NASDAQ: VACH) shareholders have approved the merger with VERAXA Biotech AG and related proposals, paving the way for the combined entity, Veraxa Biotech Holding AG, to trade on Nasdaq under the symbol VRXA. Despite the approval, a significant 99.67% of

Tone
Negative 35/100
Event
Deals and strategy
Published
18 Mar 2026 19:39
Source
Stock Titan
Intellectia AI Direct company coverage

VACHU Stock News Today | Earnings, Events & Price Alerts

This article provides recent news and events related to VACHU stock, focusing on VERAXA Biotech and Voyager Acquisition Corp. It highlights key announcements like VERAXA Biotech's co-discovery alliance with OmniAb, the business combination agreement between VERAXA Biotech and Voy

Tone
Positive 72/100
Event
Deals and strategy
Published
15 Mar 2026 10:39
Source
Intellectia AI